Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald J Buchsbaum

Showing results (21-30 of 157) with videos related to

Pageof 16
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2003
Three-dimensional dose model for the comparison of 177Lu-HuCC49DeltaCH2 and 177Lu-HuCC49 radioimunotherapy in mice bearing intraperitoneal xenograftsPeter L Roberson, Shigeru Yokoyama, Buck E Rogers, et al.
Current Medicinal Chemistry|March 7, 2019
B7-H3-targeted Radioimmunotherapy of Human CancerBenjamin B Kasten, Soldano Ferrone, Kurt R Zinn, et al.
Gynecologic Oncology|August 23, 2012
A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancerJanelle M Fauci, J Michael Straughn, Soldano Ferrone, et al.
Advances in Experimental Medicine and Biology|October 26, 2018
Novel Biomimetic Microphysiological Systems for Tissue Regeneration and Disease ModelingKarim I Budhwani, Patsy G Oliver, Donald J Buchsbaum, et al.
Immunotherapy|November 30, 2017
Modulation of antitumor immunity with histone deacetylase inhibitorsTyler R McCaw, Troy D Randall, Andres Forero, et al.
Annals of Nuclear Medicine|September 14, 2004
Gene expression imaging with radiolabeled peptidesDonald J Buchsbaum, Tandra R Chaudhuri, Masato Yamamoto, et al.
Gynecologic Oncology|February 24, 2009
Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancerPeter J Frederick, J Michael Straughn, Ronald D Alvarez, et al.
Cancer Research|February 7, 2002
Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomasC Ryan Miller, Christopher R Williams, Donald J Buchsbaum, et al.
Gynecologic Oncology|June 1, 2015
Ovarian and cervical cancer patient derived xenografts: The past, present, and futureJonathan D Boone, Zachary C Dobbin, J Michael Straughn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Brief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancerRuby F Meredith, Donald J Buchsbaum, Ronald D Alvarez, et al.
Pageof 16

Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2003
Three-dimensional dose model for the comparison of 177Lu-HuCC49DeltaCH2 and 177Lu-HuCC49 radioimunotherapy in mice bearing intraperitoneal xenograftsPeter L Roberson, Shigeru Yokoyama, Buck E Rogers, et al.
Current Medicinal Chemistry|March 7, 2019
B7-H3-targeted Radioimmunotherapy of Human CancerBenjamin B Kasten, Soldano Ferrone, Kurt R Zinn, et al.
Gynecologic Oncology|August 23, 2012
A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancerJanelle M Fauci, J Michael Straughn, Soldano Ferrone, et al.
Advances in Experimental Medicine and Biology|October 26, 2018
Novel Biomimetic Microphysiological Systems for Tissue Regeneration and Disease ModelingKarim I Budhwani, Patsy G Oliver, Donald J Buchsbaum, et al.
Immunotherapy|November 30, 2017
Modulation of antitumor immunity with histone deacetylase inhibitorsTyler R McCaw, Troy D Randall, Andres Forero, et al.
Annals of Nuclear Medicine|September 14, 2004
Gene expression imaging with radiolabeled peptidesDonald J Buchsbaum, Tandra R Chaudhuri, Masato Yamamoto, et al.
Gynecologic Oncology|February 24, 2009
Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancerPeter J Frederick, J Michael Straughn, Ronald D Alvarez, et al.
Cancer Research|February 7, 2002
Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomasC Ryan Miller, Christopher R Williams, Donald J Buchsbaum, et al.
Gynecologic Oncology|June 1, 2015
Ovarian and cervical cancer patient derived xenografts: The past, present, and futureJonathan D Boone, Zachary C Dobbin, J Michael Straughn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Brief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancerRuby F Meredith, Donald J Buchsbaum, Ronald D Alvarez, et al.
Pageof 16